22 March 2010 | Pfizer has backed its high-selling cholesterol-lowering drug Lipitor (atorvastatin) amid a new warning by US regulators linking high doses of another statin, simvastatin, to increased risk of muscle injury. 1 comment
12:00 AM | Pharmacists' role in managing medication adherence has received a boost after Pfizer joined forces with Mirixa Australia to launch a specific program targeting a major cholesterol drug
13 May 2009 | The Federal Government expects to shave off at least $113 million from its PBS expenditure by putting two popular medication in a new therapeutic group.